Mr. Speaker, I will again clarify the member's confusion.
We stated before that the FDA identified some concerns with one product that was sold in the United States. That particular product is not used in Canada. However, in taking steps to make sure that other drugs produced by Sandoz were not compromised, Health Canada did its due diligence by inspecting the plant here in Canada to ensure the quality, safety and efficacy of the drugs that were produced in that factory. We did our part to ensure that products produced by Sandoz Canada were not compromised